Argenx

Argenx and Halozyme Ink Multiple Target Deal That Could Hit $540 Million
Argenx and Halozyme Ink Multiple Target Deal That Could Hit $540 Million
BioSpace
Argenx
Halozyme Therapeutics
drug delivery
drug development
Flag link:
Should You Be Worried About the Return of Big Pharma Deals?
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
GSK
Tesaro
M&A
Big Pharma
JNJ
Argenx
Flag link:
ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
Fierce Biotech
Argenx
Cilag
Janssen
cusatuzumab
ASH2018
blood cancers
Flag link:
Argenx To Raise $300 million in U.S. public offering
Argenx To Raise $300 million in U.S. public offering
CP Wire
Argenx
Flag link:
AbbVie doubles down on cancer project with biotech group Argenx
AbbVie doubles down on cancer project with biotech group Argenx
Yahoo/Reuters
Argenx
AbbVie
ARGX-115
cancer immunotherapy
Flag link:
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug
CP Wire
Argenx
AbbVie
ARGX-115
cancer
Flag link:
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug
Argenx
Flag link:
Argenx IPO haul tops out at $115M, 50% above initial goal
Argenx IPO haul tops out at $115M, 50% above initial goal
Fierce Biotech
Argenx
IPOs
Flag link:
AbbVie Strikes Two Cancer Collaborations: Smart Move?
AbbVie Strikes Two Cancer Collaborations: Smart Move?
Bidness, ETC
AbbVie
cancer
Argenx
ARGX-115
CytomX
probodies
Flag link: